Abstract:Abstract Abstract 3853 B-cell differentiation is tightly regulated by synchronized suppression and/or induction of specific transcription factors. Among them, B-cell lymphoma 6 (BCL6) and PRDM1 are considered to be master regulators for germinal center formation and terminal B-cell differentiation. Dysregulation of BCL6 and PRDM1 also have been associated with lymphomagenesis. Their regulation still need further study especially at the posttranscriptional level. Here, by using co-culture system and whole genomic microRNA microarray profiling, we show for the first time that direct B lymphoma cell-stroma cell contact between follicular dendritic cells and B-lymphocytes could induce upregulation of miR-30 family and downregulation of miR-9 and let-7 family. In silico analysis showed that miR-30s can target genes BCL6 and miR-9/let7 can target PRDM1 with direct binding sites in 3`UTR region of their mRNAs. The microarray data can be proved by microRNA specific Q-RT-PCR. Specifically, by both gain of function and loss of function studies, we functionally verified that FDCs Regulate Expression of BCL6 and PRDM1 via Cell-Cell Direct Contact induced correlated microRNA dysregulation. To further validate the direct interaction between BCL6 and miR-30, we constructed luciferase reporters containing the BCL6 3`-UTR that included miR-30 binding sites and a mutant 3`-UTR harboring mutations in the “seed pairing” sequences of the miR-30 binding site. Co-transfection of miR-30 and reporter construct into cells significantly decreased luciferase activity in wild-type but not in mutant BCL6-3`-UTR transfected cells, supporting the role of miR-30 family in the regulation of BCL6 expression. BCL6 and PRDM1 and their regulation miRNAs, let-7 and miR-30, also can be validated in primary normal B-lymphocytes and lymphoma cells by using our co-culture system. Dysregulation of BCL6 and PRDM1 is often associated with lymphomagenesis. We firstly identified that BCL6 is the direct target of miR-30 family and also verified PRDM1 is the target of miR-9, and let-7 in our system. Our studies provide a novel mechanism of post-transcriptional regulation of BCL6 and PRDM1 by several microRNAs. In the context of micro-environment, it provides a clue for germinal center B-cell differentiation as well as B-cell lymphomas progression regulated by lymphocyte cell-stroma cell contact through microRNAs. Disclosures: No relevant conflicts of interest to declare.

Cd99 Triggers Upregulation Of Mir-9-Modulated Prdm1/Blimp1 In Hodgkin/Reed-Sternberg Cells And Induces Redifferentiation

Mir-196B Directly Targets Both HOXA9/MEIS1 Oncogenes and FAS Tumour Suppressor in MLL-rearranged Leukaemia.

Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis

Follicular Dendritic Cell-Induced Microrna-Mediated Upregulation of Prdm1 and Downregulation of Bcl-6 in Non-Hodgkin'S B-Cell Lymphomas

Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma

Microenvironment-Mediated Regulation of Micrornas in B-Lymphocytes As a Novel Mechanism for Terminal B-Cell Differentiation and Lymphomagenesis.

MiR-525-5p Modulates Cell Proliferation, Cell Cycle, and Apoptosis in Burkitt’s Lymphoma by Targeting MyD88 and Regulating the NF-κB Signaling Pathway

Primary Mediastinal Large B-cell Lymphoma: Transcriptional Regulation by Mir-92A Through FOXP1 Targeting

IL-10 Induces the Development of Immunosuppressive CD14 + HLA-DR Low/− Monocytes in B-cell Non-Hodgkin Lymphoma

Effect of shRNA targeting mouse CD99L2 gene in a murine B cell lymphoma in vitro and in vivo.

MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells

Expression of miR-9 in B lymphocytes and B cell lymphomas cell lines and its significance]

Microrna Expression Profile and Identification of Mir-29 As a Prognostic Marker and Pathogenetic Factor by Targeting CDK6 in Mantle Cell Lymphoma.

Mir-125B, a Target of CDX2, Regulates Cell Differentiation Through Repression of the Core Binding Factor in Hematopoietic Malignancies

MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma

Mir-96 Acts As a Tumor Suppressor Via Targeting the BCR-ABL1 Oncogene in Chronic Myeloid Leukemia Blastic Transformation.

Overexpression of IL-9 Induced by STAT3 Phosphorylation is Mediated by Mir-155 and Mir-21 in Chronic Lymphocytic Leukemia

Mir-99a May Serve As A Potential Oncogene in Pediatric Myeloid Leukemia

Follicular Dendritic Cell (Fdc)-Induced Microrna-Mediated Up-Regulation of PRDM1 and Down-Regulation of BCL6 in Germinal Center B Lymphocytes: A Potential Mechanism for B-Cell Differentiation.

Downregulation of Mir-152 Contributes to DNMT1-mediated Silencing of SOCS3/SHP-1 in Non-Hodgkin Lymphoma

The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type